Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harsh Batra

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cancers|November 25, 2023
Lobular Carcinoma of the Breast: A Comprehensive Review with Translational InsightsHarsh Batra, Jason Aboudi Mouabbi, Qingqing Ding, et al.
Journal of Pathology Informatics|February 3, 2026
Applications and challenges of utilizing digital pathology and AI-enabled workflows in clinical trialsManu Sebastian, Harsh Batra, Monika Lamba Saini, et al.
Histopathology|July 8, 2024
MYB expression by immunohistochemistry is highly specific and sensitive for detection of solid variant of adenoid cystic carcinoma of the breast among all triple-negative breast cancersHarsh Batra, Priya S C Bose, Yang Ding, et al.
Journal of Medical Imaging (Bellingham, Wash.)|August 2, 2023
Artificial intelligence and digital pathology: clinical promise and deployment considerationsMark D Zarella, David S McClintock, Harsh Batra, et al.
Scientific Reports|November 14, 2022
Tumor suppressor DEAR1 regulates mammary epithelial cell fate and predicts early onset and metastasis in triple negative breast cancerUyen Q Le, Nanyue Chen, Seetharaman Balasenthil, et al.
Cell Reports|September 28, 2022
Impad1 and Syt11 work in an epistatic pathway that regulates EMT-mediated vesicular trafficking to drive lung cancer invasion and metastasisRakhee Bajaj, B Leticia Rodriguez, William K Russell, et al.
JCI Insight|July 26, 2021
Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancerAparna Padhye, Jessica M Konen, B Leticia Rodriguez, et al.
Cancer Research|January 24, 2025
Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast CancerTanvi H Visal, Recep Bayraktar, Petra den Hollander, et al.
British Journal of Cancer|May 17, 2024
Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancerWarapen Treekitkarnmongkol, Vandna Shah, Kazuharu Kai, et al.
International Journal of Radiation Oncology, Biology, Physics|August 15, 2024
PRECISE: Preoperative Radiation Therapy to Elicit Critical Immune Stimulating Effects-A Phase 2 Clinical TrialSimona F Shaitelman, Huong Le-Petross, Maria G Raso, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cancers|November 25, 2023
Lobular Carcinoma of the Breast: A Comprehensive Review with Translational InsightsHarsh Batra, Jason Aboudi Mouabbi, Qingqing Ding, et al.
Journal of Pathology Informatics|February 3, 2026
Applications and challenges of utilizing digital pathology and AI-enabled workflows in clinical trialsManu Sebastian, Harsh Batra, Monika Lamba Saini, et al.
Histopathology|July 8, 2024
MYB expression by immunohistochemistry is highly specific and sensitive for detection of solid variant of adenoid cystic carcinoma of the breast among all triple-negative breast cancersHarsh Batra, Priya S C Bose, Yang Ding, et al.
Journal of Medical Imaging (Bellingham, Wash.)|August 2, 2023
Artificial intelligence and digital pathology: clinical promise and deployment considerationsMark D Zarella, David S McClintock, Harsh Batra, et al.
Scientific Reports|November 14, 2022
Tumor suppressor DEAR1 regulates mammary epithelial cell fate and predicts early onset and metastasis in triple negative breast cancerUyen Q Le, Nanyue Chen, Seetharaman Balasenthil, et al.
Cell Reports|September 28, 2022
Impad1 and Syt11 work in an epistatic pathway that regulates EMT-mediated vesicular trafficking to drive lung cancer invasion and metastasisRakhee Bajaj, B Leticia Rodriguez, William K Russell, et al.
JCI Insight|July 26, 2021
Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancerAparna Padhye, Jessica M Konen, B Leticia Rodriguez, et al.
Cancer Research|January 24, 2025
Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast CancerTanvi H Visal, Recep Bayraktar, Petra den Hollander, et al.
British Journal of Cancer|May 17, 2024
Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancerWarapen Treekitkarnmongkol, Vandna Shah, Kazuharu Kai, et al.
International Journal of Radiation Oncology, Biology, Physics|August 15, 2024
PRECISE: Preoperative Radiation Therapy to Elicit Critical Immune Stimulating Effects-A Phase 2 Clinical TrialSimona F Shaitelman, Huong Le-Petross, Maria G Raso, et al.
Pageof 2